BNP Paribas Asset Management
BMY.RT

BNP Paribas Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

BNP Paribas Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-769,397
Closed -$531K – 892
2020
Q4 		$531K Sell
769,397
-40,679
-5% -$86.6K ﹤0.01% 755
2020
Q3 		$1.82M Buy
810,076
+112,045
+16% +$320K 0.01% 604
2020
Q2 		$2.5M Buy
698,031
+45,890
+7% +$166K 0.02% 536
2020
Q1 		$2.48M Sell
652,141
-849
-0.1% -$2.8K 0.02% 517
2019
Q4 		$1.97M Buy
+652,990
New +$1.7M 0.01% 597

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

BNP Paribas Asset Management's BMY.RT Position: Q1 2021 in Review

BNP Paribas Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 769,397 shares — an estimated $531K sold.

BNP Paribas Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2.5M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • BNP Paribas Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • BNP Paribas Asset Management sold 769,397 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $531K.
  • BNP Paribas Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • BNP Paribas Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2.5M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on BNP Paribas Asset Management's 13F filing for Q1 2021, filed 5 May 2021.